期刊文献+

他汀与血管紧张素Ⅱ受体阻断剂对血管内皮祖细胞影响的研究进展

Statins and Angiotensin Ⅱ Receptor Blocker Effects on Vascular Endothelial Progenitor Cells
下载PDF
导出
摘要 他汀、血管紧张素Ⅱ受体拮抗剂具有独立于降脂、控制血压以外的血管保护作用[1]。近几年的研究表明他汀与血管内皮祖细胞正性相关,同时提示了血管内皮祖细胞在增强血管再生和损伤血管的再内皮化过程中扮演着重要的角色;血管紧张素Ⅱ受体阻断剂对血管内皮祖细胞的影响有待进一步研究确定。 Statins and angiotensin Ⅱ receptor blocker ( ARB ) possess an additional cardiovascular protective activity independent of reduction of both cholesterol and blood pressure. Recent research has show that statins positively correlate with endothelial progenitor cells ( EPCs) , and it suggested that EPCs may play an important role in enhancing vascular regeneration and reendothelialization of vascular injuries. However, the beneficial effects on EPCs after ARB are yet to be clearly established.
作者 成小凤 陈明
出处 《心血管病学进展》 CAS 2007年第5期805-808,共4页 Advances in Cardiovascular Diseases
关键词 他汀 血管紧张素Ⅱ受体阻断剂 内皮祖细胞 statins angiotensin Ⅱreceptor blocker endothelial progenitor cells
  • 相关文献

参考文献1

二级参考文献31

  • 1Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative endothelial progenitor cells for angiogenesis. Science 1997;275:964-967.
  • 2Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M,Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.Blood 2000;95:952-95
  • 3Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H,Onitsuka I, Matsui K, Imaizumi T. Transplanted cord bloodderived endothelial progenitor cells augment postnatal neovascularization. J Clin Invest 2000; 105:1527-1536.
  • 4Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Keamey M, Magner M, Isner JM, Asahara T. Ischemia- and cytokineinduced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438.
  • 5Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone mw-derived endothelial progenitor cells. EMBO J 1999; 18: 3964-3972.
  • 6Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;8
  • 7Kocher AA, Schuster MD, Szabolcs MJ, Taluma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac
  • 8Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, Mames RN, Byme BJ, Vaught T, Spoerri PE, Peck AB, Scott EW. Adult hematopoietic stem cells provide functional bemangioblast activity during retinal neovascularization. Nat Med 2002;8:607-612.
  • 9Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M,Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM.Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial pro
  • 10Hill JM, Zalos G, Halcox JP, Scbenke WH, Waclawiw MA,Quyyumi AA, Finkel T. Cirolating endothelial progenitor cells,vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部